blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2493465

EP2493465 - Treatment of sunburn using analgesics and antihistamines [Right-click to bookmark this link]
Former [2012/36]TREATMENT OF SUNBURN USING ANALGESICS AND ANTIHISTAMINES
[2014/20]
StatusNo opposition filed within time limit
Status updated on  28.08.2015
Database last updated on 20.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Sephoris Pharmaceuticals, LLC
14895 Highland Heights Road
Jamul, California 91935 / US
[2012/36]
Inventor(s)01 / SHEENA, Talal
14895 Highland Heights Road
Jamul California 91935 / US
02 / ABREO, Melwyn
3373 Armagosa Way
Jamul California 91935 / US
 [2012/36]
Representative(s)Couchman, Jonathan Hugh, et al
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2014/43]Couchman, Jonathan Hugh, et al
HGF Limited
Belgrave Hall
Belgrave Street
Leeds LS2 8DD / GB
Former [2013/29]Couchman, Jonathan Hugh, et al
Harrison Goddard Foote LLP
Belgrave Hall
Belgrave Street
Leeds LS2 8DD / GB
Former [2012/36]Harrison Goddard Foote
Belgrave Hall
Belgrave Street
Leeds
LS2 8DD / GB
Application number, filing date10828865.526.10.2010
WO2010US54157
Priority number, dateUS20090254803P26.10.2009         Original published format: US 254803 P
[2012/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011056604
Date:12.05.2011
Language:EN
[2011/19]
Type: A2 Application without search report 
No.:EP2493465
Date:05.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 12.05.2011 takes the place of the publication of the European patent application.
[2012/36]
Type: B1 Patent specification 
No.:EP2493465
Date:22.10.2014
Language:EN
[2014/43]
Search report(s)International search report - published on:KR29.09.2011
(Supplementary) European search report - dispatched on:EP23.07.2012
ClassificationIPC:A61K31/135, A61K31/192, A61K31/435, A61K31/4402, A61K31/444, A61K31/495, A61K31/5415, A61K31/554, A61K45/06, A61K31/60, A61K31/425, A61K31/19, A61K31/185, A61P29/00, A61P25/00, A61P17/00, A61P17/02
[2014/20]
CPC:
A61K31/4402 (EP,US); A61K31/135 (EP,US); A61K31/192 (EP,US);
A61K31/435 (EP,US); A61K31/444 (EP,US); A61K31/495 (EP,US);
A61K31/5415 (EP,US); A61K31/554 (EP,US); A61K31/60 (EP,US);
A61K45/06 (EP,US); A61P17/00 (EP); A61P17/02 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P37/08 (EP);
A61J1/035 (EP,US) (-)
C-Set:
A61K31/135, A61K2300/00 (US,EP);
A61K31/192, A61K2300/00 (US,EP);
A61K31/435, A61K2300/00 (EP,US);
A61K31/4402, A61K2300/00 (US,EP);
A61K31/444, A61K2300/00 (EP,US);
A61K31/495, A61K2300/00 (EP,US);
A61K31/5415, A61K2300/00 (EP,US);
A61K31/554, A61K2300/00 (EP,US);
A61K31/60, A61K2300/00 (US,EP)
(-)
Former IPC [2012/36]A61K31/135, A61K31/192, A61K31/435, A61K31/4402, A61K31/444, A61K31/495, A61K31/5415, A61K31/554, A61K45/06, A61K31/60, A61K31/425, A61K31/19, A61K31/185, A61P29/00, A61P25/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/36]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Behandlung von Sonnenbrand mit Schmerzmitteln und Antihistaminika[2014/20]
English:Treatment of sunburn using analgesics and antihistamines[2014/20]
French:Traitement de coups de soleil utilisant des analgésiques et des antihistaminiques[2014/20]
Former [2012/36]BEHANDLUNG VON SONNENBRAND MIT SCHMERZMITTELN UND ANTIHISTAMINEN
Former [2012/36]TREATMENT OF SUNBURN USING ANALGESICS AND ANTIHISTAMINES
Former [2012/36]TRAITEMENT DE COUPS DE SOLEIL UTILISANT DES ANALGÉSIQUES ET DES ANTIHISTAMINIQUES
Entry into regional phase24.05.2012National basic fee paid 
24.05.2012Search fee paid 
24.05.2012Designation fee(s) paid 
24.05.2012Examination fee paid 
Examination procedure24.05.2012Examination requested  [2012/36]
18.02.2013Amendment by applicant (claims and/or description)
25.04.2014Communication of intention to grant the patent
04.09.2014Fee for grant paid
04.09.2014Fee for publishing/printing paid
04.09.2014Receipt of the translation of the claim(s)
Divisional application(s)EP14189568.0  / EP2853262
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.04.2014
Opposition(s)23.07.2015No opposition filed within time limit [2015/40]
Fees paidRenewal fee
11.10.2012Renewal fee patent year 03
14.10.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.10.2010
AL22.10.2014
BG22.10.2014
CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
MK22.10.2014
MT22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
SM22.10.2014
TR22.10.2014
LU26.10.2014
NO22.01.2015
IS22.02.2015
[2018/46]
Former [2018/30]HU26.10.2010
BG22.10.2014
CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
MK22.10.2014
MT22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
SM22.10.2014
TR22.10.2014
LU26.10.2014
NO22.01.2015
IS22.02.2015
Former [2016/33]HU26.10.2010
BG22.10.2014
CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
MT22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
SM22.10.2014
TR22.10.2014
LU26.10.2014
NO22.01.2015
IS22.02.2015
Former [2016/32]HU26.10.2010
BG22.10.2014
CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
SM22.10.2014
TR22.10.2014
NO22.01.2015
IS22.02.2015
Former [2016/28]BG22.10.2014
CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
SM22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2016/22]CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
SM22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2016/12]CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SI22.10.2014
SK22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/37]CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
SK22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/36]CY22.10.2014
CZ22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RO22.10.2014
RS22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/35]CY22.10.2014
EE22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
MC22.10.2014
PL22.10.2014
RS22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/30]CY22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
PL22.10.2014
RS22.10.2014
BE31.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/26]CY22.10.2014
HR22.10.2014
LT22.10.2014
LV22.10.2014
PL22.10.2014
RS22.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/24]HR22.10.2014
LT22.10.2014
LV22.10.2014
PL22.10.2014
RS22.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/23]LT22.10.2014
NO22.01.2015
IS22.02.2015
Former [2015/21]LT22.10.2014
NO22.01.2015
Former [2015/20]LT22.10.2014
Documents cited:Search[XY]US3278379  (LEO MANSOR) [X] 1,4,5,9,10 * column 1, line 22 - column 2, line 18 * [Y] 1-15;
 [Y]US5100918  (SUNSHINE ABRAHAM [US], et al) [Y] 1-15 * column 7, lines 58-64 * * claim 1 *;
 [XY]WO9205783  (MERCK & CO INC [US], et al) [X] 12 * page 2, line 23 - page 3, line 2 * * page 6, lines 6-9 * * page 6, line 22 - page 7, line 26 * * examples 1, 3 * * claims 1, 3-5, 6 * [Y] 1-15;
 [X]US5993833  (DE LACHARRIERE OLIVIER [FR], et al) [X] 1,3-5,15 * example 10 *;
 [Y]WO0187236  (KLEIN GERALD L [US]) [Y] 1-15 * claims 1, 2, 7, 8, 10, 11, 13 *;
 [X]EP1284151  (RHODES DONALD A [US]) [X] 1-5,9,15 * example 9 * * column 7, paragraph [0024] * * claims 1, 8, 9, 11 *;
 [X]WO2005009342  (PHARMACIA CORP [US], et al) [X] 1,3,4,6,11 * page 6, paragraph [00022] * * page 14, paragraph [00058] * * page 130, paragraph [000175] * * page 137, paragraph [000214] * * page 138, paragraph [000217] * * table 4; compounds A26, A36, A37, A48 * * page 158, paragraphs [000230]-[000231] * * page 160, paragraph [000239] * * pages 187-188, paragraph [000333] * * claims 1, 2, 4, 7, 9, 10 *;
 [XA]WO2005079272  (WYETH CORP [US], et al) [X] 12,13 * page 2, lines 24-29 * * page 5, line 22 - page 6, line 17 * * page 7, lines 1-28 * * page 8, lines 19-23 * * example 1 * * claims 9, 14, 15 * [A] 1-11;
 [XP]WO2009145921  (FAIRFIELD CLINICAL TRIALS LLC [US], et al) [XP] 1-5,9,11,15 * page 3, paragraph [0007] - page 4, paragraph [0010] * * page 12, paragraph [0029] * * pages 13-14, paragraph [0032] ** claims 1-3, 10, 11, 19-21 *;
 [XY]  - JENS-UWE GRUNDMANN ET AL, "UV Erythema Reducing Capacity of Mizolastine Compared to Acetyl-salicylic Acid or both Combined in Comparison to Indomethacin+", PHOTOCHEMISTRY AND PHOTOBIOLOGY, (20011001), vol. 74, no. 4, doi:10.1562/0031-8655(2001)0740587UERCOM2.0.CO2, ISSN 0031-8655, pages 587 - 592, XP055032598 [X] 1,3,4,6,10,11,15 * abstract * * page 588, column 1, paragraph 5 * * page 588, column 2, paragraph 2 * * figures 1-3 * * page 589, column 1, paragraph 6 - column 2, paragraph 1 * * page 590, column 1, paragraph 3 - column 2, paragraph 1 * * page 591, column 1, paragraphs 2-3 * [Y] 1-15

DOI:   http://dx.doi.org/10.1562/0031-8655(2001)0740587UERCOM2.0.CO2
 [X]  - NAKASHIMA M ET AL, "Antihistaminic and anti-inflammatory effects of Epiamart[rho] S by topical application", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (1996), Database accession no. EMB-1997296761, XP002679915 [X] 1,3-5,11,15 * abstract *
    [ ] - NAKASHIMA M ET AL, "Antihistaminic and anti-inflammatory effects of Epiamart[rho] S by topical application", JAPANESE PHARMACOLOGY AND THERAPEUTICS 1996 JP, (1996), vol. 24, no. 10, ISSN 0386-3603, pages 91 - 95
International search[A]US5100918  (SUNSHINE ABRAHAM [US], et al);
 [A]WO9945921  (OLDFIELD FAMILY HOLDINGS PTY L [AU], et al);
 [A]US2003129209  (WALCH HATTO [DE]);
 [X]US2007014757  (CHAUHAN ABHAY S [IN], et al);
 [A]US2009196840  (LORENZO ANGELA L [US])
Examination   - HAN AMY ET AL, "Management of acute sunburn.", AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 2004, (2004), vol. 5, no. 1, ISSN 1175-0561, pages 39 - 47
    - IKAI K ET AL, "EAR SWELLING IN RESPONSE TO UV-B IRRADIATION", ARCHIVES OF DERMATOLOGICAL RESEARCH, (1986), vol. 278, no. 6, ISSN 0340-3696, pages 445 - 448
    - AKTER U ET AL, "Effects of several agents on UVB- and UVA plus systemic fluoroquinolone-induced erythema of guinea pig skin evaluated by reflectance colorimetry.", FREE RADICAL BIOLOGY & MEDICINE MAY 1998, (199805), vol. 24, no. 7-8, ISSN 0891-5849, pages 1113 - 1119
    - EDWARDS E K JR ET AL, "The effect of antihistamines on ultraviolet-light-induced erythema.", INTERNATIONAL JOURNAL OF DERMATOLOGY NOV 1983, (198311), vol. 22, no. 9, ISSN 0011-9059, pages 540 - 541
by applicantUS4861760
 US4911920
 US5212162
 US5403841
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.